Pulmonology Medical News about Burkholderia cepacia Cystic Fibrosis

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Burkholderia cepacia Complex: Impact on the Cystic Fibrosis Lung Lesion
Seminars in Respiratory and Critical Care Medicine, 09/29/09

Lynch JP – The incidence of Bcc and specific species fluctuates over time and between centers. Bcc can be transmitted by social contact, and several major epidemic strains have disseminated globally. Strict infection control measures, including cohorting (segregation) of infected patients, dramatically curtail transmission and have become the standard of care, but such measures cause social isolation, stigmatism, and psychological impact among infected patients.

<< Previous
Pemetrexed as first-line therapy for non-squamous non-small cell...

Next >>
Tissue Doppler Imaging of Right Ventricular Decompensation in...

Regulation of phenylacetic acid degradation genes of Burkholderia cenocepacia K56-2
BMC Microbiology, 10/21/09 Relevance Score: 79%

Vitamin D supplementation for cystic fibrosis
Cochrane Reviews, 10/28/09 Relevance Score: 69%

Genetic Risk Factor for Liver Disease for Patients With Cystic Fibrosis
Gastroenterology, 10/27/09 Relevance Score: 69%

Inspire Announces Presentation at the North American Cystic Fibrosis Conference and Provides Enrollment Update for Phase 3 Cystic Fibrosis Trial
Inspire, 10/16/09 Relevance Score: 69%

Pulmonary nocardiosis in cystic fibrosis
Journal of Cystic Fibrosis, 10/07/09 Relevance Score: 69%